Oncology & Rare Disease: Reach Your Goals Faster For Phase II And III Clinical Trials

Trust our technology and expertise to support your oncology and rare disease research

Cmed is a full service, global CRO with over 20 years of clinical research experience including 15 years of design and delivery of virtual and patient centric trials.

Solutions to push your clinical trial across the line

• Thorough processes to support even the most complicated patient identification, product manufacture and dose administration timeframes
• Technology enhanced safety and medical oversight using real-time visualizations to provide insights into your study data
• Established relationships with specialist laboratories, imaging, eCOA and other service providers
• Centralized and integrated data review including onsite and remote source review, plus central review including clinical, medical and data science methods